Wealthcare Advisory Partners LLC Exelixis, Inc. Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $1,795 - $2,556	-100 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$20.53 - $25.22 $2,053 - $2,522	100 New	100 $2,000
Q2 2020 Jul 29, 2020	SELL	$16.46 - $27.42 $1,646 - $2,742	-100 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $5,568 - $6,735	-300 Reduced 75.0%	100 $2,000
Q3 2017 Nov 15, 2017	BUY	$23.35 - $29.24 $9,340 - $11,696	400	400 $10,000

466

239M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $9.25B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.